Lamictal | Epilepsy Talk

“People with a history of depression have a 3 to 7 times higher risk of developing epilepsy. This kind of information is forcing us to take a second look at the interaction between depression and epilepsy” said Dr. Andres Kanner, a Professor of Clinical Neurology and Director of the Comprehensive Epilepsy Center of the University of Miami, Miller School of Medicine.

Posted in Epilepsy, Medication Issues, Research
Tags: Abilify, antidepressants, Ativan, Busperone, Celexa, Cymbalta, Doxapin, drugs, Effexor, Elavil, Epilepsy, Halcion, Klonopin, Lamictal, Lexapro, Librium, Lyrica, MAOIs, Paxil, Prozac, Remeron, risk, Seroquel, SSRI, Tofrail, Tranxene, Trazone, Valium, Valproate, Wellbutrin, Xanax

Death, Depression and AEDs

March 3, 2020
25 Comments

“Suicide Risk from 11 Anti-Epilepsy Drugs,” headlines blared across the country.

But we’re still here.

Was it sensationalism by the journalists, irresponsibility by the pharmaceutical industry or laxness of the FDA?

Posted in Epilepsy, Medication Issues, Research
Tags: anti-epilepsy drugs, depakote, depression, FDA analysis, Felbatol, Gabitril, Keppra, Lamictal, Lyrica, Neurontin, suicide risk, Tegretol, Topamax, Trileptal, Zonegran

Pregnancy with Epilepsy — Medication Dangers

July 1, 2017
4 Comments

According to the Epilepsy Foundation, mothers taking seizure medication, risk birth defects of 4 to 8 percent — compared with 2 to 3 percent for all babies. Not much of a difference.

But the risk seems to be highest when multiple seizure medications are taken. Yet, without medication, uncontrolled seizures may deprive the baby of oxygen. Seizures can also increase the risk of miscarriage or stillbirth.

So, it’s important, as you know, to get the right balance.

Increased Birth Defect Risks in Two FDA-Approved Epilepsy Medications

October 20, 2011
2 Comments

Two epilepsy drugs – Lamictal and Keppra – which are currently listed in category C may be dangerous to a fetus and should be listed in category D, according to new data. The difference between the categories is that D shows evidence of risk, but the benefits outweigh the risks…

Posted in Epilepsy, Medication Issues, News, Research
Tags: Birth Defects, dangers, Epilepsy, Keppra, Lamictal, pregnancy